Auro Laboratories Ltd.
| BSE: 530233 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE292C01011 |
| BSE 09:37 | 25 May | 96.00 |
1.05 (1.11%) |
OPEN
96.50 |
HIGH
96.50 |
LOW
96.00 |
| NSE 05:30 | 01 Jan | Auro Laboratories Ltd |
| OPEN | 96.50 |
| PREVIOUS CLOSE | 94.95 |
| VOLUME | 21 |
| 52-Week high | 195.00 |
| 52-Week low | 87.00 |
| P/E | 15.31 |
| Mkt Cap.(Rs cr) | 60 |
| Buy Price | 95.05 |
| Buy Qty | 1.00 |
| Sell Price | 95.90 |
| Sell Qty | 300.00 |
- Financial Overview
- Balance Sheet
- Profit & Loss
- Cash Flow
- Ratios
- Quarterly
- Half Yearly
- Nine Monthly
- Yearly
Filter:
Auro Laboratories Ltd. (AUROLABS) - Cash Flow
| Figures in Rs crore | 2021 | 2020 | 2019 |
| Opening Cash & Cash Equivalents | 5.68 | 4.11 | 2.25 |
| Net Cash From Operating Activities | 12.82 | 9.30 | 6.87 |
| Net Cash Used In/from Investing Activities | -3.51 | -2.21 | -3.19 |
| Net Cash Used In/from Financing Activities | -0.46 | -5.52 | -1.83 |
| Net (decrease)/increase In Cash and Cash Equivalents |
8.85 | 1.58 | 1.86 |
| Closing Cash & Cash Equivalents | 14.54 | 5.68 | 4.11 |
Quick Links for Auro Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
